Pre- and post-donation ferritin level of blood donors attending University of Calabar Teaching Hospital, Donor Clinic in Southern Nigeria

Authors

  • IM Okafor Department of Haematology and Blood Transfusion Science, Faculty of Medical Laboratory Science, College of Medical Sciences, University of Calabar, Calabar, Nigeria.
  • VO Abasi Department of Haematology and Blood Transfusion Science, Faculty of Medical Laboratory Science, College of Medical Sciences, University of Calabar, Calabar, Nigeria.
  • HU Okoroiwu Medical Laboratory Science Department, Faculty of Basic Medical Sciences, Arthur Jarvis University, Akpabuyo, Calabar.
  • CO Ogar Department of Haematology and Blood Transfusion Science, Faculty of Medical Laboratory Science, College of Medical Sciences, University of Calabar, Calabar, Nigeria.

Keywords:

post-donation, pre-donation, iron deficiency anaemia, ferritin, Blood donation

Abstract

Background: While trying to save the patient via blood transfusion, the safety of the blood donor is paramount. This study evaluated the pre- and post- donation ferritin and packed cell volume (PCV) of donors attending University of Calabar Teaching Hospital.

Method: The study adopted descriptive longitudinal approach. A total of 18 donors with age range of 18 – 48 years were enrolled and followed up for 30 days post- donation. The serum ferritin was analyzed using ELISA method while the PCV was analyzed using the microhematocrit method. Difference between means was performed using repeated measure ANOVA while post hoc was done using Bonferroni adjustment. Prediction of return to baseline values were performed using logistic regression. Alpha value was placed at
0.05.

Results: There was a decline in ferritin and packed cell volume from pre- to post-donation. The decline in ferritin was imminent until day 14 when recovery was initiated. Significant difference was observed between the predonation ferritin and the rest of the days except day 30. There was also a decline in PCV from pre-donation all through with recovery noticeable after day 7. The PCV of the pre-donation was only comparable to the day 30 postdonation. Approximately 5.6% (n=1) of the subjects was iron deficient predonation. Approximately 25% (n=4) of the subject have returned to baseline PCV while 0% of the subjects have returned to baseline ferritin at day 30 post-donation.

Conclusion: For the safety of the donor, donation interval should be widened, and iron supplement followed up.

References

Mohammed S, Essel HB. Motivational factors for blood donation, potential barriers andknowledge about blood donation in first – time and repeat blood donors. BMC Haematol. 2018; 18: 36.

Okoroiwu HU, Okafor IM. Demographic characteristics of blood and blood component transfusion recipients and pattern of blood utilization in a tertiary health institution in Southern Nigeria. BMC Haemotol. 2018; 18(16). doi.org/10.1186/s12878-018-0112-5

Ogar CO, Okpokam DC, Okoroiwu HU, Okafor IM. Comparative analysis of haematological parameters of first – time and repeat blood donors: experience of a blood bank in Southern Nigeria. Hematology, Transfusion and Cell Therapy. 2021. https://doi.org/10.1016/j.htct.2021.06.013.

Chauhan C, Chauhan R, Awashi S, Dulta S, Joshi H. Pattern and outcome of donor’s deferral: Need of hour. Int J. Res Med Sci. 2018; 6(1): 289 – 292.

World Health Organization. World Health Organization guidelines on assessing donor suitability for blood donation. WHO Library Catalogue in Publication Data. 2012. Geneva, Switzerland.

Frank B, David C, Hazel P, Matthew G. A study on the iron and AFE status of blood donors, including a group who failed the initial screen for anaemia, British Journal of Haemotology. 2016; 108; 434 – 9.

Okpokan DC, Okafor IM, Akpotuzor JO, Nna VU, Okpokan E, Osin EE, Usanya EA. Response of cellular elements to frequent blood donations among male subjects in Calabar, Nigeria. Trends in Medical Research. 2016; 11:11-19.

Ahmed SG, Kagu MB, Abjah UAM. Haemotological parameters of blood donors in North East Nigeria and the implication on quality of blood products. Africa Sanguine. 2016; 13(1): 1 - 8.

Nwankwo E, Momodu I, Umar I, Musa B, Adeleke S. Seroprevalence of major blood – borne infections among blood donors in Kano Nigeria. Turk J. Med. 2012; 42 (2): 337-341

Okoroiwu HU, Okafor IM, Asemoto EA, Okpokam DC. Seroprevalence of transfusion transmissible infectious (HBV, HCV,Syphilis and HIV) among prospective blood donors in a tertiary healthcare facility in Calabar, Nigeria:

an eleven years evaluation. BMC public Health. 2018; 18: 645. doi.org/10.1186/s12889-018-5555-x.

Sorensen BS, Johnsen SP, Jorgensen J. Complications related to blood donation: a population base study. Vox Sang. 2008; 94 (2): 132 – 137.

Moghadan AM, Natanzi MM, Djalali M, Saedisomeolia A, et al. Realationship between blood donor’s iron status and their age, body mass index and donation frequency. Sao Paulo Med J. 2013; 131 (6): 377 - 383.

Javadzadeh SH, Attar M, Taher YM. A study of the prevalence of iron deficiency and its related factors in blood donors of Yazd, Iran, 2003. 2005; 15(4): 287 – 93.

Nah EH, Cho HI, kim S. Subclinical iron deficiency in non – anemic individuals: retrospective analysis of Korea Health Examinees. Acts Haematol. 2020; 143 (1): 26 – 32.

Skikine B, Lynch S. Borek D, cook J. Iron and blood donation. Clin. Haematol. 1984; 13 (1): 271 – 287.

Okafor IM, Antai AB, Usanga EA. Evaluation of soluble transferrin receptor / ferritin ratio and other iron related parameters of pregnant women in Cross River State, Nigeria. Tropical Journal of Medical Research. 2017; 5: 56 – 62.

Okafor IM, Okpokan DC, Antai AB, Usanga EA. Soluble transferrin receptor as a marker of diagnosis of iron deficiency anaemia, a study in Calabar. International Journal of Biomedical Laboratory Science. 2014; 3: 40 – 46.

Oyira EJ, Ndiok AE, Ademuyiwa IY. Challenges and Nurses Job Performance in the University of Calabar Teaching Hospital, Calabar, Cross River State, Nigeria. Sumerians Journal of Medical and Health Care. 2019; 2(9):

– 118.

Ekere FE, Useh MF, Okoroiwu HU, Mirabeau TY, Cysteine – cysteine Chemokine receptor 5 (CCR5) profile of HIV – infected subjects attending University of Calabar Teaching Hospital, Calabar, Southern, Nigeria. BMC infectious Disease. 2020; 20 (5). doi.org/10.1186/s12879-019-4737-1.

Ogar CO, Okoroiwu HU, Obeagu EI, Etura JE, AbunimiyeDA. Assessment of blood supply and usage pre- and during COVID - 19pandemic: a lesson from non –voluntary donation. Transfusion Clinique et Biologique. 2021; 28: 68 – 72.

World Health Organization WHO guideline on use of ferritin concentration to assess iron status in individuals and population. Geneva: World Health Organization. 2020. Geneva, Switzerland.

Canadian Blood Services. Available at: https:// www.blood.ca. Accessed 16 May, 2022.

European Commission. Commission directive 2004/33/EC. Official journal of the European Union. 2004; L91: 25 – 39.

Scholten N, Pasker – de Jong PCM, Moretti D, Zimmermann MB, Geurts – Moespot AJ, et al. The donation interval of 56days require extension to 180 days for while blood donors to recover from changes in iron metabolism. Blood. 2016; 128 (17): 2185 – 2188.

Kautz L, Nemeth E. Molecular liaisons between erythropoiesis and iron metabolism. Blood. 2014; 124 (4): 479 – 482.

Leggett BA, Brown NN, Bryant SJ, Duplock L, Powell LW, Halliday JW. Factors affecting the concentrations of ferritin in serum in healthy Australian population. Clin Chem. 1990; 36(7): 1350-5.

Downloads

Published

2023-10-08

How to Cite

Okafor , I., Abasi , V., Okoroiwu , H., & Ogar , C. (2023). Pre- and post-donation ferritin level of blood donors attending University of Calabar Teaching Hospital, Donor Clinic in Southern Nigeria. The Nigerian Health Journal, 23(3), 750–757. Retrieved from https://tnhjph.com/index.php/tnhj/article/view/717

Issue

Section

Original Articles

Similar Articles

1 2 3 4 5 6 7 8 > >> 

You may also start an advanced similarity search for this article.